Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Operating Expenses: 2022-2025

Historic Operating Expenses for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $78.4 million.

  • Praxis Precision Medicines' Operating Expenses rose 37.14% to $78.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $300.6 million, marking a year-over-year increase of 81.48%. This contributed to the annual value of $208.7 million for FY2024, which is 62.02% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported Operating Expenses of $78.4 million as of Q3 2025, which was up 3.01% from $76.1 million recorded in Q2 2025.
  • Praxis Precision Medicines' Operating Expenses' 5-year high stood at $78.4 million during Q3 2025, with a 5-year trough of $26.0 million in Q3 2023.
  • In the last 3 years, Praxis Precision Medicines' Operating Expenses had a median value of $42.3 million in 2024 and averaged $51.5 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first plummeted by 43.68% in 2023, then skyrocketed by 152.18% in 2024.
  • Praxis Precision Medicines' Operating Expenses (Quarterly) stood at $41.5 million in 2022, then tumbled by 31.68% to $28.3 million in 2023, then surged by 152.18% to $71.4 million in 2024, then surged by 37.14% to $78.4 million in 2025.
  • Its Operating Expenses stands at $78.4 million for Q3 2025, versus $76.1 million for Q2 2025 and $74.7 million for Q1 2025.